ORIGINALES
Efectos cutáneos adversos causados por erlotinib
Adverse cutaneous reactions to erlotinib
Leído
25277
Vecesse ha leído el artículo
3156
Total PDF
22121
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 119 | 26 | 145 |
| 2025 5 | 159 | 43 | 202 |
| 2025 4 | 175 | 47 | 222 |
| 2025 3 | 194 | 28 | 222 |
| 2025 2 | 218 | 27 | 245 |
| 2025 1 | 257 | 42 | 299 |
| 2024 12 | 234 | 41 | 275 |
| 2024 11 | 150 | 79 | 229 |
| 2024 10 | 135 | 52 | 187 |
| 2024 9 | 155 | 40 | 195 |
| 2024 8 | 158 | 63 | 221 |
| 2024 7 | 144 | 50 | 194 |
| 2024 6 | 145 | 55 | 200 |
| 2024 5 | 145 | 48 | 193 |
| 2024 4 | 175 | 41 | 216 |
| 2024 3 | 138 | 34 | 172 |
| 2024 2 | 156 | 52 | 208 |
| 2024 1 | 142 | 36 | 178 |
| 2023 12 | 202 | 26 | 228 |
| 2023 11 | 154 | 32 | 186 |
| 2023 10 | 124 | 29 | 153 |
| 2023 9 | 152 | 54 | 206 |
| 2023 8 | 128 | 46 | 174 |
| 2023 7 | 134 | 75 | 209 |
| 2023 6 | 93 | 42 | 135 |
| 2023 5 | 73 | 11 | 84 |
| 2023 4 | 142 | 38 | 180 |
| 2023 3 | 136 | 27 | 163 |
| 2023 2 | 136 | 28 | 164 |
| 2022 1 | 117 | 33 | 150 |
| 2022 12 | 164 | 27 | 191 |
| 2022 11 | 140 | 43 | 183 |
| 2022 10 | 109 | 26 | 135 |
| 2022 9 | 124 | 66 | 190 |
| 2022 8 | 165 | 51 | 216 |
| 2022 7 | 180 | 41 | 221 |
| 2022 6 | 114 | 35 | 149 |
| 2022 5 | 127 | 32 | 159 |
| 2022 4 | 125 | 30 | 155 |
| 2022 3 | 109 | 33 | 142 |
| 2022 2 | 97 | 21 | 118 |
| 2021 1 | 165 | 46 | 211 |
| 2021 12 | 107 | 37 | 144 |
| 2021 11 | 99 | 44 | 143 |
| 2021 10 | 137 | 56 | 193 |
| 2021 9 | 151 | 58 | 209 |
| 2021 8 | 124 | 31 | 155 |
| 2021 7 | 99 | 31 | 130 |
| 2021 6 | 112 | 24 | 136 |
| 2021 5 | 99 | 34 | 133 |
| 2021 4 | 197 | 33 | 230 |
| 2021 3 | 133 | 39 | 172 |
| 2021 2 | 113 | 32 | 145 |
| 2020 1 | 123 | 35 | 158 |
| 2020 12 | 118 | 23 | 141 |
| 2020 11 | 92 | 27 | 119 |
| 2020 10 | 70 | 12 | 82 |
| 2020 9 | 84 | 16 | 100 |
| 2020 8 | 100 | 21 | 121 |
| 2020 7 | 79 | 13 | 92 |
| 2020 6 | 103 | 21 | 124 |
| 2020 5 | 78 | 12 | 90 |
| 2020 4 | 67 | 14 | 81 |
| 2020 3 | 72 | 11 | 83 |
| 2020 2 | 8 | 2 | 10 |
| 2019 12 | 1 | 0 | 1 |
| 2019 11 | 3 | 0 | 3 |
| 2019 10 | 1 | 0 | 1 |
| 2019 7 | 1 | 1 | 2 |
| 2019 5 | 0 | 3 | 3 |
| 2019 4 | 1 | 10 | 11 |
| 2019 3 | 1 | 5 | 6 |
| 2019 2 | 2 | 4 | 6 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 22 | 0 | 22 |
| 2018 11 | 8 | 4 | 12 |
| 2018 10 | 12 | 0 | 12 |
| 2018 9 | 5 | 1 | 6 |
| 2018 8 | 1 | 0 | 1 |
| 2018 7 | 0 | 1 | 1 |
| 2018 5 | 5 | 0 | 5 |
| 2018 4 | 1 | 1 | 2 |
| 2018 3 | 4 | 1 | 5 |
| 2018 2 | 134 | 7 | 141 |
| 2018 1 | 118 | 8 | 126 |
| 2017 12 | 117 | 11 | 128 |
| 2017 11 | 122 | 11 | 133 |
| 2017 10 | 124 | 7 | 131 |
| 2017 9 | 269 | 10 | 279 |
| 2017 8 | 354 | 6 | 360 |
| 2017 7 | 276 | 5 | 281 |
| 2017 6 | 231 | 7 | 238 |
| 2017 5 | 208 | 9 | 217 |
| 2017 4 | 197 | 6 | 203 |
| 2017 3 | 263 | 5 | 268 |
| 2017 2 | 255 | 9 | 264 |
| 2016 1 | 130 | 9 | 139 |
| 2016 12 | 168 | 4 | 172 |
| 2016 11 | 241 | 5 | 246 |
| 2016 10 | 257 | 14 | 271 |
| 2016 9 | 284 | 12 | 296 |
| 2016 8 | 211 | 7 | 218 |
| 2016 7 | 84 | 7 | 91 |
| 2016 6 | 11 | 11 | 22 |
| 2016 5 | 5 | 5 | 10 |
| 2016 4 | 13 | 4 | 17 |
| 2016 3 | 8 | 3 | 11 |
| 2016 2 | 5 | 2 | 7 |
| 2015 1 | 7 | 9 | 16 |
| 2015 12 | 14 | 5 | 19 |
| 2015 11 | 101 | 15 | 116 |
| 2015 10 | 105 | 7 | 112 |
| 2015 9 | 28 | 10 | 38 |
| 2015 8 | 27 | 9 | 36 |
| 2015 7 | 356 | 1 | 357 |
| 2015 6 | 317 | 8 | 325 |
| 2015 5 | 357 | 24 | 381 |
| 2015 4 | 281 | 25 | 306 |
| 2015 3 | 365 | 14 | 379 |
| 2015 2 | 322 | 10 | 332 |
| 2015 1 | 289 | 14 | 303 |
| 2014 12 | 272 | 26 | 298 |
| 2014 11 | 364 | 22 | 386 |
| 2014 10 | 383 | 11 | 394 |
| 2014 9 | 332 | 16 | 348 |
| 2014 8 | 357 | 23 | 380 |
| 2014 7 | 300 | 18 | 318 |
| 2014 6 | 308 | 26 | 334 |
| 2014 5 | 302 | 17 | 319 |
| 2014 4 | 256 | 13 | 269 |
| 2014 3 | 230 | 33 | 263 |
| 2014 2 | 199 | 17 | 216 |
| 2014 1 | 188 | 22 | 210 |
| 2013 12 | 267 | 17 | 284 |
| 2013 11 | 182 | 18 | 200 |
| 2013 10 | 153 | 15 | 168 |
| 2013 9 | 182 | 18 | 200 |
| 2013 8 | 214 | 26 | 240 |
| 2013 7 | 198 | 19 | 217 |
| 2013 6 | 178 | 16 | 194 |
| 2013 5 | 184 | 14 | 198 |
| 2013 4 | 172 | 23 | 195 |
| 2013 3 | 149 | 16 | 165 |
| 2013 2 | 164 | 8 | 172 |
| 2013 1 | 364 | 5 | 369 |
| 2012 12 | 173 | 12 | 185 |
| 2012 11 | 71 | 9 | 80 |
| 2012 10 | 38 | 5 | 43 |
| 2012 9 | 6 | 2 | 8 |
| 2012 8 | 0 | 1 | 1 |
| 2011 5 | 4 | 0 | 4 |
| 2011 4 | 8 | 0 | 8 |
| 2011 3 | 6 | 0 | 6 |
| 2011 2 | 9 | 0 | 9 |
| 2010 1 | 13 | 0 | 13 |
| 2010 12 | 16 | 0 | 16 |
| 2010 11 | 11 | 0 | 11 |
| 2010 10 | 58 | 0 | 58 |
| 2010 9 | 19 | 0 | 19 |
| 2010 8 | 8 | 0 | 8 |
| 2010 7 | 15 | 0 | 15 |
| 2010 6 | 14 | 0 | 14 |
| 2010 5 | 41 | 0 | 41 |
| 2010 4 | 23 | 0 | 23 |
| 2010 3 | 10 | 0 | 10 |
| 2010 2 | 7 | 0 | 7 |
| 2009 1 | 6 | 0 | 6 |
| 2009 12 | 10 | 0 | 10 |
| 2009 11 | 5 | 0 | 5 |
| 2009 10 | 7 | 0 | 7 |
| 2009 9 | 27 | 0 | 27 |
| 2009 8 | 28 | 0 | 28 |
| 2009 7 | 21 | 0 | 21 |
| 2009 6 | 22 | 0 | 22 |
| 2009 5 | 18 | 0 | 18 |
| 2009 4 | 18 | 0 | 18 |
| 2009 3 | 27 | 0 | 27 |
| 2009 2 | 7 | 0 | 7 |
| 2009 1 | 16 | 0 | 16 |
| 2008 12 | 19 | 0 | 19 |
| 2008 11 | 11 | 0 | 11 |
| 2008 10 | 33 | 0 | 33 |
| 2008 9 | 27 | 0 | 27 |
| 2008 8 | 13 | 0 | 13 |
| 2008 7 | 14 | 0 | 14 |
| 2008 6 | 19 | 0 | 19 |
| 2008 5 | 21 | 0 | 21 |
| 2008 4 | 1 | 0 | 1 |
| 2008 2 | 1 | 0 | 1 |
| 2008 1 | 5 | 0 | 5 |
Mostrar todo
